Ludwig Boltzmann Institute for Traumatology, The Research Center in Cooperation with AUVA

What Ludwig Boltzmann Institute for Traumatology, The Research Center in Cooperation with AUVA does

LBI Trauma is a Vienna-based non-profit research institute founded in 1980 as part of the Ludwig Boltzmann Gesellschaft (LBG) network and operated under a core strategic partnership with AUVA (Allgemeine Unfallversicherungsanstalt), Austria's statutory accident insurance institution. It is the dedicated research arm serving AUVA's 7 trauma hospitals and 4 rehabilitation centers, conducting translational research that spans preclinical models through clinical application in trauma care, sepsis, organ failure, and regenerative medicine. The institute employed 66 staff and operated 12 specialized research groups plus two competence centers as of the latest disclosed period.

Name

Ludwig Boltzmann Institute for Traumatology, The Research Center in Cooperation with AUVA

Legal name

Ludwig Boltzmann Gesellschaft – Österreichische Vereinigung zur Förderung der wissenschaftlichen Forschung

Website

https://trauma.lbg.ac.at

Company type

Private

Founded year

1980

Operating status

Operating

Headcount range

51–100 employees

Short description

LBI Trauma is a Vienna-based non-profit research institute founded in 1980 under the Ludwig Boltzmann Gesellschaft, operating as the dedicated research center for AUVA's trauma hospital and rehabilitation network, conducting translational research in traumatology, sepsis, organ failure, and regenerative medicine across 12 specialized groups.

Ownership category

akta.pro rank

Product category

Trauma and Regenerative Medicine Research

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171), Specialty (except Psychiatric and Substance Abuse) Hospitals (622310)

SIC

Services-Commercial Physical & Biological Research (8731), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Orthopedic Trauma (HLAKALAD)

akta.pro secondary industries

Ambulatory Wound Care & Hyperbaric Oxygen Therapy Centers (HLAFABAG), Trauma Centers & Level I–IV Trauma Hospitals (HLAFAAAK)

Keywords

• Trauma research services
• Regenerative medicine research
• Sepsis and shock studies
• Tissue engineering research
• Biomedical research institute

Headquarters

HQ city

Vienna

HQ country

Austria

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure

Distribution channels1 record

Marketing channels6 records

Core offering

The Ludwig Boltzmann Institute for Traumatology is a non-profit biomedical research center that conducts preclinical and clinical research in traumatology, regenerative medicine, sepsis, organ failure, and tissue regeneration. It operates 12 specialized research groups and two competence centers (HABIT histology/bioimaging and the Clinical Center for Studies in Regenerative Medicine), delivering research outputs and innovations directly to AUVA's 7 trauma hospitals and 4 rehabilitation centers as well as to the broader scientific community through publications and collaborations.

Product overview

The Ludwig Boltzmann Institute for Traumatology operates as a research center with multiple specialized research programs rather than a commercial product company. Its portfolio includes 12 research groups covering trauma, sepsis, organ failure, regeneration medicine, and various tissue types (bone, cartilage, nerve, soft tissue). The institute also maintains two competence centers (HABIT for histology/bioimaging and Clinical Center for Regenerative Medicine) and participates in collaborative projects including the Austrian Cluster for Tissue Regeneration, NanoPrecMed nanomedicine consortium, and TeleHealthAid telemedicine initiative. Research approaches include photobiomodulation, shockwave therapy, and cell-based therapies using stem cells from sources like amnion and adipose tissue.

Differentiator

Problem solved

Functional benefit

Products and services

• SHIELD Research Program Prevention research program covering occupational safety, emerging technologies, nanomaterials, CMR substances, and endocrine disruptors, including photobiomodulation (LED light therapy) for wound healing, infection control, and ischemic tissue repair.
• Sepsis-Trauma-Shock Research Research program on pathological processes underlying sepsis and septic shock, including development of the MQTiPSS international guidelines for preclinical sepsis studies.
• Molecular Basis of Organ Failure and Regeneration Research on molecular mechanisms of trauma-, shock-, and inflammation-induced organ failure, focusing on mitochondria, endoplasmic reticulum, and redox biology.
• HABIT Histology and Bioimaging Core Facility Core competence center providing advanced histology, bioimaging, and micro-CT scanning services for traumatology and regenerative medicine research.
• Clinical Center for Studies in Regenerative Medicine Clinical competence center advancing regenerative medicine studies and clinical applications of cell-based therapies and tissue engineering.
• Neuroregeneration Research Program Research on regeneration of central and peripheral nervous system, including spinal cord injury and peripheral nerve regeneration focused on hand injuries.
• Cartilage Regeneration Research Program Research on articular cartilage tissue engineering and regeneration for joint injury treatment.
• Bone Regeneration Research Program Research on bone and ligament bioengineering and regeneration, including osteoporosis, fracture healing, and 3D-printed biomaterial implants (INKplant project).
• Shoulder Regeneration Research Program Research focused on rotator cuff tear treatment and shoulder joint regeneration.
• Cell-based Therapies Research Program Research on stem cell therapy and cell-based treatments for tissue regeneration, including mechanical extraction of stem cells from adipose tissue and amnion-derived stem cell applications.
• Extracellular Biotechnology Research Program Research on extracellular vesicles and biotechnology applications for regenerative medicine.
• Local Haemostasis and Soft Tissue Regeneration Research on local bleeding control and soft tissue regeneration, including shockwave therapy and photobiomodulation approaches.
• Translational Anesthesiology and Pain Medicine Research bridging anesthesiology and pain medicine for trauma patient care.
• Tissue Damage Responses in Regeneration and Aging Research on tissue damage responses during regeneration and aging processes.
• NanoPrecMed Consortium Cross-border Czech-Austrian nanomedicine research consortium funded by INTERREG AT-CZ, coordinated by LBI Trauma.
• TeleHealthAid Telemedicine Project Telemedicine project for healthcare provision in structurally weak regions.
• Austrian Cluster for Tissue Regeneration Multi-institutional research cluster coordinating tissue regeneration research across 29-30 groups from 11-13 leading Austrian research institutions.

Quantifiable outcome

• MQTiPSS guidelines for preclinical sepsis research published in 2018 and adopted internationally to standardize sepsis study quality
• +2 more outcomes

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

13 partnerships are on record, tiered core, flagship and minor.

• Wiggers-Bernard InitiativecoreStrategic or Co-development Partner · 1 January 2018International expert initiative coordinated by LBI Trauma (Marcin Osuchowski) that published the MQTiPSS (Minimum Quality Threshold in Pre-Clinical Sepsis Studies) guidelines in 2018 to standardize preclinical sepsis research globally. Guidelines published in Intensive Care Medicine Experimental, Infection, and Shock journals.
• Austrian Cluster for Tissue Regeneration (Österreichischer Cluster für Geweberegeneration)flagshipStrategic or Co-development Partner · 1 December 2006Founded in December 2006 with the goal of sharing knowledge and resources to jointly advance tissue regeneration research. Originally comprising founding members including LBI Trauma, Medical University of Vienna, Vienna University Dental Clinic, and Upper Austrian Red Cross. Now comprises 29-30 groups from 11-13 leading Austrian research institutions. Coordinated by Univ. Prof. Dr. Heinz Redl from LBI Trauma.
• AUVA (Austrian Workers' Compensation Board / Allgemeine Unfallversicherungsanstalt)coreStrategic or Co-development PartnerAUVA is Austria's statutory accident insurance institution responsible for prevention, acute care, rehabilitation, and reintegration following occupational and leisure-time accidents. The institute serves as AUVA's dedicated research center, directly supplying its 7 trauma hospitals and 4 rehabilitation centers with innovative findings in traumatology and regenerative medicine. This is the institute's founding and primary strategic partnership.
• Medical University of Vienna (Medizinische Universität Wien)coreStrategic or Co-development PartnerFounding member of the Austrian Cluster for Tissue Regeneration. Collaborates with LBI Trauma on joint research in tissue regeneration, including neuroregeneration, bone and cartilage regeneration, and wound healing.
• University of Minho, 3B's Research Group (Portugal)minorStrategic or Co-development PartnerInternational research partner where LBI Trauma researcher Conny Schneider gained doctoral experience. Collaborates on biomaterials and tissue engineering research.
• Erasmus Medical Center Rotterdam (Netherlands)minorStrategic or Co-development PartnerInternational research partner where LBI Trauma researcher Conny Schneider gained doctoral experience. Collaborates on cartilage tissue engineering with Prof. Gerjo van Osch.
• NanoPrecMed ConsortiumflagshipStrategic or Co-development PartnerCross-border Czech-Austrian nanomedicine consortium funded by INTERREG AT-CZ. Coordinated by LBI Trauma's Conny Schneider. Focuses on network building, cross-border collaboration, and technology transfer between Austria and the Czech Republic.
• BEATsepsis ConsortiumflagshipStrategic or Co-development PartnerLarge European research project dedicated to improving long-term outcomes after sepsis. LBI Trauma's Conny Schneider leads science communication for this initiative.
• LBG SHoW (Ludwig Boltzmann Gesellschaft Open Innovation)minorStrategic or Co-development PartnerInterdisciplinary group within LBG promoting open and participatory research approaches. LBI Trauma team members contribute Co-Creation Team activities and Open Innovation strategies.
• ESICM (European Society of Intensive Care Medicine)minorStrategic or Co-development PartnerESICM produces educational videos used by the Sepsis-Trauma-Shock research group at LBI Trauma, with permission for distribution on the institute's platform.
• TERMIS (Tissue Engineering and Regenerative Medicine International Society)minorOthersInternational professional society. LBI Trauma's Conny Schneider serves on the Outreach Committee and Event Endorsement Committee. The institute actively participates in TERMIS-EU Congresses.
• MuSkITYR (Musculoskeletal Interdisciplinary Translational Young Researchers)minorOthersPlatform by and for early-career researchers to foster interdisciplinary collaboration in musculoskeletal research. LBI Trauma's Conny Schneider serves as Board Member. Hosts the MuSkITYR Symposium (VIII. edition in Hamburg, November 2026).
• MechanoBiology Competence CentreminorStrategic or Co-development PartnerCzech-Austrian cross-border cooperation funded under an Interreg programme. LBI Trauma is one of three Austrian members. Joint research on how mechanical forces affect tissue and cells and how this can stimulate the body's own healing process.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Regional players

• Vienna BioCenter: Major Vienna-based life sciences research cluster with overlapping biomedical research scope; relevant regional comparable rather than a direct competitor given LBI Trauma's trauma and regenerative medicine specialization.

Direct peers

• Rizzoli Orthopaedic Institute: Italian orthopedic specialty research and clinical institution directly comparable on bone, cartilage, and musculoskeletal regeneration research with a similar hospital-embedded research mission.
• Fraunhofer Institute for Cell Therapy and Immunology (IZI): Applied biomedical research institute with comparable focus on cell-based therapies, regenerative medicine, and translation of preclinical findings into clinical applications, supported by a similar public-mandate funding model.
• Helmholtz Centre for Infection Research (HZI): Large publicly funded research center with deep overlap to LBI Trauma's Sepsis-Trauma-Shock research and inflammatory disease programs, sharing a comparable publicly funded, multi-program research model.
• Steadman Philippon Research Institute: Specialized orthopedic research institute with overlapping focus on cartilage, ligament, and shoulder regeneration, and a similar translational research-to-clinical-practice model anchored to a sports medicine hospital network.
• Ludwig Boltzmann Institute for Lung Vascular Research: Sibling institute under the Ludwig Boltzmann Gesellschaft, operating with the same parent organization, governance structure, and publicly funded research-institute model as LBI Trauma, making it a structural peer.
• Erasmus MC Department of Orthopaedics and Sports Medicine: Active international research partner of LBI Trauma on cartilage tissue engineering; comparable on cartilage regeneration research and academic-clinical integration, though operating at much larger institutional scale.
• AO Research Institute Davos (ARI): Applied orthopedic and trauma research institute closely comparable to LBI Trauma in mission, scope, and clinical-translation model, with similar regenerative medicine programs in bone, cartilage, and fracture healing.

Broad incumbents

• Karolinska Institutet: Large research-intensive medical university with substantial regenerative medicine, sepsis, and trauma research programs; comparable on research depth but operates across all medical specialties at much greater scale.
• Medical University of Vienna (MedUni Wien): Larger academic medical center and founding member of the Austrian Cluster for Tissue Regeneration; comparable on regenerative medicine research but operates at much greater scale across all medical disciplines.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/ludwig-boltzmann-institute-for-experimental-and-clinical-traumatology

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ludwig Boltzmann Institute for Traumatology, The Research Center in Cooperation with AUVA